Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor anthracyclines prepared at Pharmacia & Upjohn

March 27, 1998

Imutec Pharma begins preclinical development of antitumor agents

March 27, 1998

Disappointing preliminary phase III results for lisofylline in BMT

March 27, 1998

FDA advisory committee recommends Taxol for new indications

March 27, 1998

New drug therapy option for colonic polyps described

March 27, 1998

Differentiation-inducing retinoyloxy(substituted)alkylene butyrates from Bar-Ilan

March 26, 1998

Northwest Hospital's prostate cancer vaccine shows promise in phase I/II; new trial sites added

March 26, 1998

Angiogenesis-inhibitory monokine available for licensing from NIH

March 25, 1998

New agents for PDT reported by Yeda

March 25, 1998

New antitumor agents discovered by Toagosei

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...